Chemoinformaics analysis of Dihydrozeatin riboside
Molecular Weight | 353.379 | nRot | 7 |
Heavy Atom Molecular Weight | 330.195 | nRig | 16 |
Exact Molecular Weight | 353.17 | nRing | 3 |
Solubility: LogS | -1.74 | nHRing | 3 |
Solubility: LogP | -0.794 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 5 | No. of Arom Atom | 9 |
No. of Oxygen atom | 5 | No. of Arom Bond | 10 |
nHA | 10 | APOL | 49.8962 |
nHD | 5 | BPOL | 30.5098 |
QED | 0.415 |
Synth | 4.507 |
Natural Product Likeliness | 1.378 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.982 |
HIA | 0.979 |
CACO-2 | -5.379 |
MDCK | 0.00000866 |
BBB | 0.66 |
PPB | 0.148211 |
VDSS | 0.825 |
FU | 0.724402 |
CYP1A2-inh | 0.016 |
CYP1A2-sub | 0.149 |
CYP2c19-inh | 0.011 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.499 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.048 |
CYP3a4-inh | 0.023 |
CYP3a4-sub | 0.104 |
CL | 9.17 |
T12 | 0.772 |
hERG | 0.032 |
Ames | 0.057 |
ROA | 0.676 |
SkinSen | 0.084 |
Carcinogencity | 0.058 |
EI | 0.009 |
Respiratory | 0.863 |
NR-Aromatase | 0.921 |
Antiviral | No |
Prediction | 0.580966 |